No Data
Express News | Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 5.26 Million in Common Stocks
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading
BioNTech Price Target Raised to $171.44/Share From $171.00 by Canaccord Genuity
BioNTech Is Maintained at Buy by Canaccord Genuity
Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $150
A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $122 to $171.44